Regulation - Brazil

Filter

Current filters:

Brazil

Popular Filters

Proposal to expand the quality control of medicines sold in Brazil

Proposal to expand the quality control of medicines sold in Brazil

18-08-2014

Brazilian House Bill 6763/13 introduced by Gorete Pereira (PR-EC) sets the standards to ensure the quality…

BrazilPharmaceuticalProductionRegulation

Brazil plans to update the regulatory framework, expand production of medical products

Brazil plans to update the regulatory framework, expand production of medical products

15-08-2014

The Brazilian Ministry of Health has opened a public consultation to establish the criteria for product…

BrazilFederal governmentPharmaceuticalProductionRegulation

Updated legislation may boost phytotherapic drug production in Brazil

Updated legislation may boost phytotherapic drug production in Brazil

14-07-2014

Pharma companies are unsure of the extent of the commercialization of phytotherapic drugs in Brazil,…

BrazilPharmaceuticalRegulation

Brazil’s ANVISA opens public consultation on bioavailability/bioequivalence of medicines

Brazil’s ANVISA opens public consultation on bioavailability/bioequivalence of medicines

04-07-2014

The Brazilian National Health Surveillance Agency, ANVISA, has initiated a public consultation to review…

BrazilPharmaceuticalRegulation

ANVISA proposes new rules to expedite the approval of clinical research in Brazil

ANVISA proposes new rules to expedite the approval of clinical research in Brazil

05-06-2014

The Brazilian National Health Surveillance Agency (ANVISA) recently presented a proposal with new rules…

BrazilPharmaceuticalRegulation

Congressional hearing in Brazil will discuss the efficacy of generic medicines

26-05-2014

The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness…

BrazilGenericsPoliticsRegulation

Brazil Senate discusses pathways for advancement of clinical research

Brazil Senate discusses pathways for advancement of clinical research

20-03-2014

The Brazilian Senate's Social Affairs Committee (CAS) held a hearing on March 18 to debate the progress…

BrazilPharmaceuticalRegulationResearch

Brazil initiates public consultation on interchangeability of biosimilar drugs

Brazil initiates public consultation on interchangeability of biosimilar drugs

17-01-2014

Biosimilar drugs, also known as follow-on biologics, may soon be substituted in place of the reference…

BiosimilarsBrazilPharmaceuticalRegulationSouth America

Rapid uptake of rheumatoid arthritis biosimilars expected in Brazil and Mexico

19-12-2013

Biosimilars will be quickly acquired and used in public health institutions in the treatment of patients…

Anti-Arthritics/RheumaticsBiosimilarsBrazilGenericsMarkets & MarketingRegulationSouth America

Brazil’s ANVISA and ProGenericos sign cooperation agreement

Brazil’s ANVISA and ProGenericos sign cooperation agreement

18-12-2013

Brazil's National Health Surveillance Agency, ANVISA has signed a memorandum of technical and operational…

BiosimilarsBrazilGenericsRegulationResearchSouth America

Brazil's regulatory processes impair the growth of pharma industry

Brazil's regulatory processes impair the growth of pharma industry

06-12-2013

The Brazilian pharmaceutical market is considered the second with the greatest growth potential in the…

BrazilPharmaceuticalRegulationSouth America

Back to top